Related Experiment Video
Updated: Oct 2, 2025

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Coronary artery calcium scores indicating secondary prevention level risk: Findings from the CAC consortium and
Omar Dzaye1, Alexander C Razavi2, Erin D Michos3
1Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Insights
High coronary artery calcium (CAC) scores in primary prevention patients can indicate atherosclerotic cardiovascular disease (ASCVD) mortality risks similar to secondary prevention patients. This suggests a risk continuum between these groups.
Area of Science:
- Cardiology
- Preventive Medicine
- Epidemiology
Background:
- Coronary artery calcium (CAC) scoring is associated with atherosclerotic cardiovascular disease (ASCVD) risk.
- The FOURIER trial provided data on ASCVD mortality in a secondary prevention cohort.
Purpose of the Study:
- To determine CAC scores in primary prevention patients equivalent to ASCVD mortality rates observed in the FOURIER trial.
- To explore the risk continuum between primary and secondary prevention patients.
Main Methods:
- Analysis of 20,207 participants from the CAC Consortium aged ≥50 with a 10-year ASCVD risk ≥7.5%.
- Utilized Poisson regression to model the relationship between CAC and annual ASCVD mortality.
- Derived equivalent CAC scores based on observed ASCVD mortality rates in FOURIER placebo participants.
Main Results:
- An annualized ASCVD mortality rate of 0.766 per 100 person-years in FOURIER corresponded to a CAC score of 781 (418-1467).
- A CAC score of 255 (162-394) matched the ASCVD mortality rate of the lowest-risk FOURIER subgroup.
- No CAC score replicated the risk of high-risk FOURIER subgroups (e.g., symptomatic PAD, multivessel CAD).
Conclusions:
- Elevated CAC burden in primary prevention may confer ASCVD mortality risks comparable to stable secondary prevention.
- Findings support a continuous spectrum of ASCVD risk overlapping between higher-risk primary prevention and stable secondary prevention populations.
Background And Aims:
Coronary artery calcium (CAC) burden displays a stepwise association with atherosclerotic cardiovascular disease (ASCVD) risk. Among primary prevention patients, we sought to determine the CAC scores equivalent to ASCVD mortality rates observed in the FOURIER trial, a modern secondary prevention cohort.
Methods And Results:
For the main analysis, we included participants from the CAC Consortium ≥50 years old with a 10-year ASCVD risk ≥7.5% (n = 20,207). Poisson regression was used to define the relationship between CAC and annual ASCVD mortality. Equations generated from the regression models were then used to derive CAC scores associated with equivalent annual ASCVD mortality as observed in FOURIER placebo participants from the overall trial and in key trial subgroups. The CAC Consortium participants had a similar age (65.5 versus 62.5 years) and sex (22% versus 24% female) distribution as FOURIER. The annualized ASCVD mortality rate in FOURIER participants (0.766 per 100 person-years) corresponded to a CAC score of 781 (418-1467). A CAC score of 255 (162-394) corresponded to an ASCVD mortality rate equivalent to the lowest risk FOURIER subgroup (presence of myocardial infarction >2 years prior to trial enrollment). No CAC score produced a risk equivalent to high-risk FOURIER subgroups, particularly those with symptomatic peripheral arterial disease and/or multivessel coronary heart disease.
Conclusions:
Primary prevention individuals with increased CAC burden may have annualized ASCVD mortality rates equivalent to persons with stable secondary prevention-level risk. These findings argue for a risk continuum between higher risk primary prevention and stable secondary prevention patients, as their ASCVD risks may overlap.
More Related Videos
06:57Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests